High-copy IncP-2 megaplasmid carrying blaAFM in clinical difficult-to-treat resistance Pseudomonas aeruginosa: Associated with high-level cefiderocol resistance - 13/02/25
Doi : 10.1016/j.jinf.2025.106422
Wenhao Wu 1
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Meijun Song 2
Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China
Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Department of Respiratory, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China
Xi Li
Center of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China
Piaopiao Zhang
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Yue Li, Heng Cai, Yan Jiang
Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China
Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Yunsong Yu ⁎ 
Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China
Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
Department of Infectious Diseases, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China
∗Corresponding author.
Tingting Qu ⁎
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Infection Control Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
∗∗Corresponding author.
Le texte complet de cet article est disponible en PDF.
Plan
© 2025
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 90 - N° 2
Article 106422- février 2025 Retour au numéro
Article précédent
- Optimization of Diphtheria, Tetanus and Pertussis (DTP) vaccination strategy in China
- Shimo Zhang, Jue Liu
- Declining COVID-19 vaccination coverage in Brazil: A global health warning
- Milena Silva Souza, Jéssica Pires Farias, Luís Carlos de Souza Ferreira, Jaime Henrique Amorim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?